News & Event
Initiation of the GLP Certification Process Toward the Highest Quality Standards
We have fully initiated the official procedures for obtaining GLP certification and are systematically preparing all required documentation and compliance measures.
Signs Strategic Preclinical Research Agreement with Pharminvivo
Through this collaboration, the two companies will jointly conduct in vivo efficacy and safety evaluations of microneedle (MN) technology. Pharminvivo is led by Professor Zsuzsanna Helyes of the University of Pécs, Hungary.
This partnership marks a significant milestone in EaseJect’s development of microneedle platforms for biopharmaceutical applications, establishing a strong foundation for an integrated preclinical-to-clinical research framework within Hungary.
EaseJect aims to accelerate the clinical translation of its microneedle drug delivery technology for next-generation vaccines and therapeutics, and to strengthen its position as a central research hub for microneedle-based biopharmaceutical evaluation in Europe.
Recognized as R&D Company
This recognition:
Strengthens our professional credibility within Hungary’s innovation ecosystem, Builds trust with government institutions and business partners, Provides access to national R&D funding and collaboration opportunities, And accelerates the momentum of our ongoing and future R&D projects, both domestically and internationally.
With this certification, we are committed to contributing even more actively to Hungary’s innovation goals and global competitiveness.